CORPORATE GOVERNANCE

XVIVO Perfusion

XVIVO PERFUSION Magnus Nilsson hands the baton of CEO and Group head of XVIVO Perfusion to Dag Andersson

April 28, 2020

Press release

Share

ADDRESS: NYBROGATAN 6, 114 34 STOCKHOLM, SWEDEN

PHONE: +46 8 614 00 20

EMAIL: INFO@BURE.SE

Bure was founded in 1992 from the winding up of Sweden’s wage earner investment funds and was listed on Nasdaq Stockholm in 1993. Our goal is to create value and returns for our shareholders by actively developing a diversified portfolio of professionally managed companies and businesses. The cornerstones of our business model are in-depth engagement and a strong presence in the portfolio companies. In this way, we build up extensive expertise in the industries in which our portfolio companies operate. Our current portfolio includes several companies with which we have been involved for a long time and to which we have contributed to successful development.

Copyright © 2020 Bure Equity AB.
All rights reserved.